Hemophilia screening

Hemophilia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemophilia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemophilia screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemophilia screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemophilia screening
CDC on Hemophilia screening
Hemophilia screening in the news
Blogs on Hemophilia screening
Directions to Hospitals Treating Hemophilia
Risk calculators and risk factors for Hemophilia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.

Screening

• Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT).
• Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.